Headache in multiple sclerosis

Current Pain and Headache Reports

Volumn 14, Issue 4, 2010, Pages 316-320

  Putzki, Norman ^a,b   Katsarava, Zaza ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Glatiramer acetate; Headache; Interferon beta; Multiple sclerosis; Pain; Trigeminal neuralgia

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; GLATIRAMER; IBUPROFEN; PARACETAMOL; PREDNISONE;

BEDTIME DOSAGE; CASE STUDY; CAUSAL ATTRIBUTION; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG WITHDRAWAL; EVENING DOSAGE; FLU LIKE SYNDROME; HEADACHE; HUMAN; MIGRAINE AURA; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATIENT ASSESSMENT; PERIAQUEDUCTAL GRAY MATTER; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT OUTCOME; TRIGEMINAL AUTONOMIC CEPHALALGIA;

ANIMALS; HEADACHE; HUMANS; MULTIPLE SCLEROSIS;

EID: 77956393044     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0126-6     Document Type: Review

References (37)

1. Archibald CJ, McGrath PJ, Ritvo PG, et al.: Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 1994, 58:89-93.
2. Clifford DB, Trotter JL: Pain in multiple sclerosis. Arch Neurol 1984, 41:1270-1272.
3. Moulin DE, Foley KM, Ebers GC: Pain syndromes in multiple sclerosis. Neurology 1988, 38:1830-1834.
4. Stenager E, Knudsen L, Jensen K: Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand 1991, 84:197-200.
5. Stovner LJ, Hagen K, Jensen R, et al.: The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193-210. This article is an excellent overview of global burden of headache that also shows regional differences.
6. Freedman MS, Gray TA: Vascular headache: A presenting symptom of multiple sclerosis. Can J Neurol Sci 1989, 16:63-66.
7. Rolak LA, Brown S: Headaches and multiple sclerosis: A clinical study and review of the literature. J Neurol 1990, 237:300-302.
8. D'Amico D, La Mantia L, Rigamonti A, et al.: Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 2004, 11:980-984.
9. Haas DC, Kent PF, Friedman DI: Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993, 33:452-455.
10. Fragoso YD, Brooks JB: Two cases of lesions in brainstem in multiple sclerosis and refractory migraine. Headache 2007, 47:852-854.
11. Galer BS, Lipton RB, Weinstein S, et al.: Apoplectic headache and oculomotor nerve palsy: An unusual presentation of multiple sclerosis. Neurology 1990, 40:1465-1466.
12. Barkhof F, Filippi M, Miller DH, et al.: Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120:2059-2069.
13. Cooney BS, Grossman RI, Farber RE, et al.: Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache 1996, 36:616-621.
14. Jacome DE, Leborgne J: MRI studies in basilar artery migraine. Headache 1990, 30:88-90.
15. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA: Infarcts in the posterior circulation territory in migraine. The populationbased MRI CAMERA study. Brain 2005, 128:2068-2077.
16. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA: Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006, 37:1109-1112.
17. Knight YE, Goadsby PJ. The periaqueductal gray matter modulates trigeminovascular input: A role in migraine? Neuroscience 2001, 106:793-800.
18. Gee JR, Chang J, Dublin AB, Vijayan N: The association of brainstem lesions with migraine-like headache: An imaging study of multiple sclerosis. Headache 2005, 45:670-677.
19. Watkins SM, Espir M: Migraine and multiple sclerosis. J Neurol Neurosurg Psychiatr 1969, 32:35-37.
20. Putzki N, Pfriem A, Limmroth V, et al.: Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 2009, 16:262-267. This article covers a populationbased case-control study according to new International Headache Society diagnostic criteria, one of the largest epidemiological studies on prevalence of headache syndromes in MS.
21. Göbel H, Petersen-Braun M, Soyka D: The epidemiology of headache in Germany: A nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994, 14:97-106.
22. Lampl C, Buzath A, Baumhackl U, Klingler D: One-year prevalence of migraine in Austria: A nation-wide survey. Cephalalgia 2003, 23:280-286.
23. Lipton RB, Bigal ME, Diamond M, et al.: Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343-349. This article is recommended for better understanding of the need for treatment of migraine that also gives insight on consequences of migraine for the social security systems.
24. Lantéri-Minet M, Valade D, Géraud G, et al.: Migraine and probable migraine: Results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 2005, 25:1146-1158.
25. Stewart WF, Lipton RB, Celentano DD, Reed ML: Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992, 267:64-69.
26. Zivadinov R, Willheim K, Sepic-Grahovac D, et al.: Migraine and tension-type headache in Croatia: A population-based survey of precipitating factors. Cephalalgia 2003, 23:336-343.
27. Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381-383.
28. Rieckmann P, Toyka KV: Escalating immunotherapy of multiple sclerosis. Austrian-German-Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. Eur Neurol 1999, 42:121-127.
29. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, doubleblind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 1993, 43:655-661.
30. Jacobs LD, Cookfair DL, Rudick RA, et al.: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996, 39:285-294.
31. Published erratum appears in Ann Neurol 1996, 40:480.
32. La Mantia, D'Amico D, Rigamonti A, et al.: Interferon treatment may trigger primary headaches in multiple sclerosis patients. Mult Scler 2006, 12:476-480.
33. Pöllmann W, Erasmus LP, Feneberg W, et al.: Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002, 59:636-639.
34. Vacca G, Marano E, Brescia Morra V, et al.: Multiple sclerosis and headache co-morbidity. A case-control study. Neurol Sci 2007, 28:133-135.
35. Pöllmann W, Erasmus LP, Feneberg W, Straube A: The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS. Neurology 2006, 66:275-277.
36. Reess J, Haas J, Gabriel K, et al.: Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsingremitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy. Mult Scler 2002, 8:15-18.
37. Río J, Nox C, Bonaventure I, et al.: Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: A randomized trial. Neurology 2004, 63:525-528.